Moderna Announces IND Submitted to US FDA for Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus | Vaccines | News Channels - PipelineReview.com
Moderna Announces IND Submitted to US FDA for Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus | Vaccines | News Channels PipelineReview.com
Comments
Post a Comment